Old Web
English
Sign In
Acemap
>
authorDetail
>
Liangliang Zhang
Liangliang Zhang
Foundation Medicine
Medicine
Immunohistochemistry
Internal medicine
Oncology
androgen independent
3
Papers
1
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
ERBB2 copy number (CN) as a quantitative biomarker for real-world (RW) outcomes to anti-HER2 therapy in advanced gastroesophageal adenocarcinoma (adv GEA).
2021
Journal of Clinical Oncology
Samuel J. Klempner
Liangliang Zhang
Ryon Graf
Russell Madison
Jeremy Snider
Cheryl D. Cho-Phan
Emily Castellanos
Gerald Li
Halla Nimeiri
Garrett M. Frampton
Geoffrey R. Oxnard
Jeffrey Venstrom
Kimberly McGregor
Alexa Betzig Schrock
Show All
Source
Cite
Save
Citations (1)
Concordance of HER2+ status by IHC/ISH and ERBB2 status by NGS in a real-world clinicogenomic database and analysis of outcomes in patients (pts) with metastatic breast cancer (mBC).
2021
Journal of Clinical Oncology
Cheryl D. Cho-Phan
Jeremy Snider
Liangliang Zhang
Kimberly McGregor
Alexa Betzig Schrock
Emily Castellanos
Show All
Source
Cite
Save
Citations (0)
Molecular, immunologic, and clinicodemographic landscape of MYC-amplified (MYCamp) advanced prostate cancer (PCa).
2021
Journal of Clinical Oncology
Brandon A. Mahal
Liangliang Zhang
Mohamed Alshalalfa
Ryon Graf
Hanna Tukachinsky
Richard S.P. Huang
Kimberly McGregor
Alexa Betzig Schrock
Jeffrey Venstrom
Show All
Source
Cite
Save
Citations (0)
1